 | |||||
| today deals | |||||
| NEWS | |||||
| AstraZeneca picks up a friend for Tagrisso in $40M upfront deal - Fierce Biotech Allorion's EGFR inhibitor is designed to address mechanisms of resistance to current therapies, Chief Scientific Officer Fang Li, PhD., said in ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment